ADHD Assessments and Medical Cannabis: A Joined-Up Approach to Support

Living with Attention Deficit Hyperactivity Disorder (ADHD) can be challenging, especially when symptoms affect focus, emotional regulation, sleep, or day-to-day functioning. For many people, accessing the right diagnosis and treatment can feel complex and overwhelming. That’s why we offer a streamlined approach that combines professional ADHD assessments with access to medical cannabis prescriptions where clinically appropriate.

Our aim is simple: to help you get the clarity, support, and treatment options you need in one coordinated pathway.

Getting an ADHD diagnosis: Why it matters

An ADHD diagnosis is often the first and most important step towards understanding your symptoms and accessing appropriate support. In the UK, ADHD is recognised as a neurodevelopmental condition that can affect both children and adults. Symptoms may include difficulties with concentration, impulsivity, hyperactivity, emotional dysregulation, and problems with organisation or time management.

Without a formal diagnosis, many people struggle to access workplace adjustments, educational support, or specialist medical treatment. A clear diagnosis can also bring reassurance, helping individuals better understand their experiences and explore evidence-based treatment options.

What does an ADHD assessment involve?

A full ADHD assessment is carried out by a qualified healthcare professional with expertise in neurodevelopmental conditions. The process typically includes:

• A detailed clinical interview covering childhood and adult symptoms
• A review of medical, mental health, and family history
• Use of validated diagnostic criteria (DSM-5 or ICD-11)
• Input from questionnaires or reports, where appropriate

Some patients may also complete an ADHD Test as part of the assessment process. These tests help clinicians understand how symptoms present in daily life, but they are always interpreted alongside a full clinical evaluation.

Our service can arrange ADHD assessments promptly, helping to reduce the long waiting times often associated with NHS pathways.

ADHD treatment options: Where medical cannabis fits in

In the UK, first-line treatments for ADHD usually include behavioural strategies and licensed medications such as stimulants or non-stimulants. However, these treatments are not suitable or effective for everyone. Some patients experience limited symptom relief or find side effects difficult to manage.

Medical cannabis has been legal in the UK since 2018 and can be prescribed privately by specialist doctors when other treatment options have not been effective or tolerated. While cannabis is not a first-line treatment for ADHD, some patients report benefits in areas such as:

• Sleep regulation
• Anxiety management
• Emotional regulation
• Overall quality of life

Prescriptions are considered on an individual basis, following a comprehensive clinical review. Any cannabis prescription for ADHD is made under specialist care and in line with current UK regulations.

A combined, patient-centred service

If you believe you may have ADHD and are also exploring alternative treatment options, we can support you at every stage. Should you require an ADHD diagnosis, we can help get you the support you need, from assessment through to personalised treatment planning.

By offering both ADHD assessments and access to specialist cannabis clinicians, we aim to provide a joined-up, transparent, and patient-centred service. This ensures continuity of care, clear communication, and treatment decisions that are always guided by your individual needs and current clinical evidence.

Taking the next step

Whether you are seeking clarity through an ADHD assessment, exploring treatment options after diagnosis, or looking for alternatives where conventional medications haven’t worked, support is available.

If you’re ready to begin, our team can guide you through the assessment process and discuss all appropriate treatment options, helping you make informed decisions about your health and wellbeing.